This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuo, P. T. Articles by Moreyra, A. E. Search for Related Content PubMed PubMed Citation Articles by Kuo, P. T. Articles by Moreyra, A. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Carbohydrates Dietary Fats Hazardous Substances DB CHOLESTEROL

Circulation, Vol 59, 199-211, Copyright © 1979 by American Heart Association

ARTICLES

Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia

PT Kuo, K Hayase, JB Kostis and AE Moreyra

Long-term effects of diet and colestipol (a bile acid sequestrant) were studied in 25 patients with familial type II hyperlipoproteinemia. Serum lipids and body weights of an initial group of 30 patients were stabilized by low cholesterol-saturated fat-refined carbohydrate diet and the patients were then randomized into placebo and drug-treatment groups. After explaining that the drug is nontoxic and effective in lowering serum lipids, total cholesterol (C) and low-density lipoprotein cholesterol (LDL-C), colestipol (30 g/day) and diet were given to the 25 patients who remained in the long-term follow-up program. The treatment resulted in highly significant lowering of serum lipids (mg/dl, mean +/- SEM): C and LDL-C from 412.7 +/- 24.4 and 331.1 +/- 22.8 to 270 +/- 11.0 and 188.1 +/- 13.8, respectively (p less than 0.001 in each instance) over 7--7 1/2 years. Although we observed no absolute increase in high density lipoprotein (HDL), the HDL/LDL ratio was elevated. Long-term colestipol and diet treatment reduced the xanthoma size and stabilized serially angiographically visualized atherosclerotic lesions in 21 of the 25 patients who showed a satisfactory hypolipemic response. It did not cause nutritional or metabolic disturbances.

This article has been cited by other articles:

				R. M. Fleming, K. Ketchum, D. M. Fleming, and R. Gaede Assessing the Independent Effect of Dietary Counseling and Hypolipidemic Medications on Serum Lipids Angiology, September 1, 1996; 47(9): 831 - 840. [Abstract] [PDF]

				R. M. Fleming, K. Ketchum, D. M. Fleming, and R. Gaede Treating Hyperlipidemia in the Elderly Angiology, December 1, 1995; 46(12): 1075 - 1083. [Abstract] [PDF]